risk reward updat
reason chang
updat estim compani pre-announc
well updat currenc forecast updat ep
previous ep previous
chemic unit state america
unless otherwis note metric base modelwar
base consensu methodolog
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
price price target base base ebitda
modest premium multipl reect posit mix shift
signic acquisit dupont spin-off commod orient lithium
within equal-weight ag construct
best class multi-year growth
stori function innov product
penetr rather cyclic dynam
believ well understood
lot equiti market like
visibl market growth sale
compound-annual-growth-rate versu industri
ii portfolio less reliant peer
us/latam corn soybean drive
growth iii crop chemic
seed busi held back recent year
lack price/mix expens
revers ytd
certainti re-expans
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
apr gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
valuat re-rat best class growth
valuat re-rat best class growth
high end histor seed/crop chem
high end histor seed/crop chem
multipl revenu compound-annual-growth-rate
pipelin hit rate appear greater
expect sale target appear
conserv becom appar
ebitda margin expand
expect like
convers better expect capit
return sharehold ahead expect
price sticki raw
issu fx headwind ultim abat
convers improv expect post-
patent licens plan execut pipelin
product launch time ramp toward
diamid address market smaller
diamid address market smaller
new product registr product
new product registr product
slow rais concern
enough room licens volum
product struggl regulatori
registr launch late slower
continu above-market sale growth
pipelin product advanc
china india
view explan region hierarchi
research highest favor quintil
new activ ingredi launch ramp faster
expect
diamid portfolio continu outperform
convers improv more/earli
diamid address market smaller
fx raw materi headwind
convers improv much
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
